• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控制眼部血管生成的因素。

Factors controlling ocular angiogenesis.

作者信息

Casey R, Li W W

机构信息

Charles R. Drew University of Medicine and Science, University of California, Los Angeles, USA.

出版信息

Am J Ophthalmol. 1997 Oct;124(4):521-9. doi: 10.1016/s0002-9394(14)70868-2.

DOI:10.1016/s0002-9394(14)70868-2
PMID:9323943
Abstract

PURPOSE

To provide an overview of the cellular and molecular factors involved in ocular angiogenesis.

METHODS

A literature search and review encompassing a broad range of medical and basic science disciplines was undertaken to survey contemporary insights into the mechanisms of angiogenic stimulation and inhibition.

RESULTS

Ocular angiogenesis is a complex pathophysiologic process. Factors have been isolated that play key roles in the regulation of angiogenesis. The influence of stimulating growth factors is counterbalanced by a number of antiproliferative agents. The net result of these opposing factors on the vascular endothelial cell determines the outcome of angiogenesis homeostasis. Both endogenous and synthetic molecules can regulate ocular angiogenesis.

CONCLUSIONS

The isolation and synthesis of molecular regulators of angiogenesis has enhanced our understanding of this process. Clinical trials are underway to determine the efficacy of these agents in controlling pathologic angiogenesis, including that in ocular disease.

摘要

目的

概述眼部血管生成中涉及的细胞和分子因素。

方法

进行了一项涵盖广泛医学和基础科学学科的文献检索与综述,以审视对血管生成刺激和抑制机制的当代见解。

结果

眼部血管生成是一个复杂的病理生理过程。已分离出在血管生成调节中起关键作用的因素。刺激生长因子的影响被多种抗增殖剂所抵消。这些相互对立的因素对血管内皮细胞的最终作用决定了血管生成稳态的结果。内源性和合成分子均可调节眼部血管生成。

结论

血管生成分子调节剂的分离与合成增进了我们对这一过程的理解。目前正在进行临床试验,以确定这些药物在控制病理性血管生成(包括眼部疾病中的血管生成)方面的疗效。

相似文献

1
Factors controlling ocular angiogenesis.控制眼部血管生成的因素。
Am J Ophthalmol. 1997 Oct;124(4):521-9. doi: 10.1016/s0002-9394(14)70868-2.
2
[Mechanism of angiogenesis. Ocular involvement].
Oftalmologia. 2003;59(4):3-8.
3
Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.视网膜外新生血管形成的玻璃体中的内皮细胞刺激血管生成因子
Invest Ophthalmol Vis Sci. 1989 Oct;30(10):2174-8.
4
Angiogenic and angiostatic factors in the molecular control of angiogenesis.血管生成分子调控中的血管生成和血管生成抑制因子
Q J Nucl Med. 2003 Sep;47(3):149-61.
5
[Factors influencing ocular angiogenesis].[影响眼部血管生成的因素]
Vestn Oftalmol. 2009 May-Jun;125(3):52-5.
6
Angiostatic and angiogenic factors.血管生成抑制因子和血管生成因子。
Dev Ophthalmol. 2010;46:1-3. doi: 10.1159/000320005. Epub 2010 Aug 10.
7
Angiogenesis.
Curr Atheroscler Rep. 1999 Sep;1(2):165-71. doi: 10.1007/s11883-999-0013-y.
8
Ocular neovascularization. Experimental animal model and studies on angiogenic factor(s).眼部新生血管形成。实验动物模型及血管生成因子研究。
Int Ophthalmol. 1986 May;9(2-3):109-20. doi: 10.1007/BF00159839.
9
[The role of the endothelium in angiogenesis].[内皮细胞在血管生成中的作用]
Rev Med Chir Soc Med Nat Iasi. 1997 Jan-Jun;101(1-2):31-9.
10
Review of the ocular angiogenesis animal models.眼部血管生成动物模型综述。
Semin Ophthalmol. 2009 Mar-Apr;24(2):52-61. doi: 10.1080/08820530902800017.

引用本文的文献

1
Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing downstream signaling in endothelial cells.基于实验的计算模型预测,IL-6 经典信号转导和转导信号在诱导内皮细胞下游信号转导方面具有相似的效力。
NPJ Syst Biol Appl. 2023 Sep 21;9(1):45. doi: 10.1038/s41540-023-00308-2.
2
Traumatic Intralenticular Neovascularization in a HLA B27+ Pediatric Patient.一名 HLA B27 阳性儿科患者的创伤性晶状体内新生血管形成
Diagnostics (Basel). 2021 Aug 18;11(8):1493. doi: 10.3390/diagnostics11081493.
3
Proteomic analysis of anti-angiogenic effects by conbercept in the mice with oxygen induced retinopathy.
康柏西普对氧诱导视网膜病变小鼠抗血管生成作用的蛋白质组学分析
Int J Ophthalmol. 2020 Dec 18;13(12):1844-1853. doi: 10.18240/ijo.2020.12.02. eCollection 2020.
4
CircRNA Is a Rising Star in Researches of Ocular Diseases.环状RNA是眼科疾病研究中的一颗新星。
Front Cell Dev Biol. 2020 Sep 3;8:850. doi: 10.3389/fcell.2020.00850. eCollection 2020.
5
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model.组蛋白去乙酰化酶抑制剂 AN7 可减轻小鼠脉络膜新生血管模型中的病变。
Int J Mol Sci. 2019 Feb 7;20(3):714. doi: 10.3390/ijms20030714.
6
Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage.新型苯酞亚胺类似物治疗角膜新生血管和视网膜血管渗漏的疗效。
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3630-3642. doi: 10.1167/iovs.18-24015.
7
Assessment of Global and Local Alterations in Retinal Layer Thickness in Ins2 (Akita) Diabetic Mice by Spectral Domain Optical Coherence Tomography.通过光谱域光学相干断层扫描评估Ins2(Akita)糖尿病小鼠视网膜层厚度的全局和局部改变。
J Ophthalmol. 2018 Feb 20;2018:7253498. doi: 10.1155/2018/7253498. eCollection 2018.
8
Clinical Efficacy and Safety of the EX-PRESS Filtration Device in Patients with Advanced Neovascular Glaucoma and Proliferative Diabetic Retinopathy.EX-PRESS滤过装置在晚期新生血管性青光眼和增殖性糖尿病视网膜病变患者中的临床疗效与安全性
Case Rep Ophthalmol. 2018 Jan 23;9(1):61-69. doi: 10.1159/000479363. eCollection 2018 Jan-Apr.
9
Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages.术前玻璃体内注射贝伐单抗对不同阶段新生血管性青光眼手术疗效的影响
J Ophthalmol. 2017;2017:7672485. doi: 10.1155/2017/7672485. Epub 2017 Jun 20.
10
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma.阿拉马迪环植入术在新生血管性青光眼治疗中的疗效。
Clin Ophthalmol. 2017 Mar 20;11:541-548. doi: 10.2147/OPTH.S128956. eCollection 2017.